 |
Investor Contact:
Maureen Resac
Maureen.Resac@Adtalem.com
312-651-1481
Media Contact:
John Kristoff
John.Kristoff@Adtalem.com
312-651-1437
|
Adtalem Global Education Announces Fiscal Fourth Quarter and Full Year 2020 Results
Revenue increased 3.8% from prior year as COVID-19 impacted results in third and fourth quarters
Company continues to enhance portfolio and position itself for future growth
CHICAGO – August 18, 2020 – Adtalem Global
Education Inc. (NYSE: ATGE), a leading workforce solutions provider, today reported academic, operating and financial results for its fiscal 2020 fourth quarter and full year ended June 30, 2020.
“Fiscal 2020 was another pivotal year for Adtalem as we worked to advance our Workforce Solutions Provider strategy, beginning with the divestiture of
our Brazil assets, which further streamlined Adtalem to drive significant shareholder value while also fortifying our balance sheet. Although we faced significant headwinds as a result of the COVID-19 pandemic in the second half of the year, our
teams reacted quickly, leveraging our existing infrastructure to transition 15,000 on-campus students to our online platforms with minimal disruption, bringing the total number of online students to 40,000 students. The transition to virtual
modalities across our businesses was very successful, enabling us to not only maintain superior academic outcomes for learners, but to also open up new opportunities to serve our institutional and employer partners,” said Lisa Wardell, chairman and
CEO of Adtalem.
“We continue to strategically position the company for future growth. We have streamlined the portfolio to provide comprehensive solutions to employers
in both medical and healthcare and financial services – industries where supply and demand imbalances will drive growth in upskilling, certifications, and degree enrollment. The pandemic has allowed us to leverage our robust e-learning
capabilities and drive continued progress in solving complex issues for hospital systems and proactively assisting financial institutions as they respond to accelerated digital banking and cryptocurrency risk and compliance issues while navigating
the “new normal” of increased digital banking and virtual assets,” concluded Wardell.
Financial Highlights
Selected financial data for the three months ended June 30, 2020:
|
●
|
Revenue of $259.7 million decreased 1.7% compared with the prior year, reflecting negative impacts from the COVID-19 pandemic
|
|
●
|
New and total May student enrollments in Medical and Healthcare increased 5.9% and 6.9%, respectively
|
|
●
|
Diluted loss per share was $4.86 compared with diluted earnings per share of $0.86 in the prior year; diluted earnings per share from
continuing operations, excluding special items, was $0.58, compared to $0.66 in the prior year
|
|
●
|
Operating income from continuing operations was $21.7 million compared with $54.8 million in the prior year; operating income from continuing
operations, excluding special items, was $40.0 million, a 23.2% decrease compared with the prior year, reflecting negative impacts from the COVID-19 pandemic
|
|
●
|
Net loss attributable to Adtalem was $256.1 million, driven by a loss from discontinued operations of $327.6 million, compared with net income
attributable to Adtalem of $49.5 million in the prior year; net income from continuing operations attributable to Adtalem, excluding special items, was $30.5 million, a 19.3% decrease compared with the prior year
|
Selected financial data for the twelve months ended June 30, 2020:
|
●
|
Revenue of $1,052.0 million increased 3.8% compared with the prior year
|
|
●
|
Diluted loss per share was $1.58 compared with diluted earnings per share of $1.60 in the prior year; diluted earnings per share from
continuing operations, excluding special items, was $2.28, compared to $2.29 in the prior year
|
|
●
|
Operating income from continuing operations was $142.3 million compared with $155.8 million in the prior year; operating income from continuing
operations, excluding special items, was $166.1 million, a 9.1% decrease compared with the prior year
|
|
●
|
Net loss attributable to Adtalem was $85.3 million, driven by a loss from discontinued operations of $329.3 million, compared with net income
attributable to Adtalem of $95.2 million in the prior year; net income from continuing operations attributable to Adtalem, excluding
special items, was $123.5 million, a 9.3% decrease compared with prior year
|
|
●
|
COVID-19 negatively impacted certain aspects of our business in both our segments. We estimate the negative impact of COVID-19 to fiscal year
2020 revenue of $29 million, operating income of $19 million and diluted earnings per share in the range of $0.27 to $0.29, with the large majority of this impact occurring in the fourth quarter
|
Fiscal 2020 fourth quarter results contained special items including total pre-tax restructuring charges of $18.3 million ($28.6 million for the twelve months ended June 30, 2020), the majority of which are related to Adtalem’s home office real estate consolidations and workforce
reductions. The workforce reductions were driven by the desire to become more cost effective in response to the COVID-19 pandemic. In addition, a loss from discontinued operations of $327.6 million ($329.3 million for the twelve months ended June
30, 2020) was offset by a hedge gain of $26.9 million ($110.7 million for the twelve months ended June 30, 2020) on the deal-contingent hedge arrangement entered into in connection with the sale of Adtalem Brazil completed on April 24, 2020. The
arrangement hedged the Brazilian Real denominated purchase price through mitigation of the currency exchange rate risk. Finally, a $25.7 million net tax benefit for a former subsidiary investment loss was recorded during the fourth quarter and the
twelve months ended June 30, 2020.
Segment Highlights
Medical and Healthcare
Fourth quarter segment revenue of $211.4 million was flat compared with the prior year.
Chamberlain revenue in the fourth quarter increased 9.1% compared with the prior year. New and total student enrollment for the May 2020 session increased 5.4% and 8.2%, respectively, compared
with the prior year.
Revenue in the fourth quarter for the medical and veterinary schools decreased 12.9% compared with the prior year, with the decline driven entirely by
COVID-19, which resulted in reduced clinical weeks at the medical schools and loss of housing revenue during the quarter.
Segment operating income in the fourth quarter decreased 0.3% to $39.6 million compared with the prior year. The slight decrease in segment operating
income is the result of the decline in revenue for the medical and veterinary schools as well as corporate costs that were previously allocated to our former Business and Law segment, partially offset by strong student enrollment and efforts to
reduce travel and discretionary spend.
Financial Services
Fourth quarter segment revenue decreased 9.7% to $48.3 million compared with the prior year, reflecting negative impacts from COVID-19. This decline was
driven primarily by the cancellation of ACAMS in person conferences and a decrease in Becker Accounting revenue. Becker Accounting revenue decreased 14.4% compared with the prior year, driven by the delay of CPA testing due to the closure of
testing centers during the COVID-19 pandemic as well as constrained customer spending. Fourth quarter segment revenue included $5.0 million of inorganic revenue
growth from the May 2019 acquisition of OnCourse Learning, the increase of which more than offset the decrease in revenue from the sale of Becker’s healthcare assets. Segment operating income decreased 54.0% to $6.8 million compared with the prior
year. The decrease in segment operating income is the result of the impacts of the COVID-19 pandemic on revenue, an increase in marketing and sales investment to support future sales growth, and corporate costs that were previously allocated to
our former Business and Law segment. Excluding special items, segment operating income in the fourth quarter decreased 46.9% to $8.5 million.
Adtalem Outlook
Due to continued uncertainty surrounding the full impact of the COVID-19 pandemic, Adtalem will not be providing guidance for fiscal year 2021 at this
time. Over the long-term, the company remains confident in its ability to generate meaningful growth in revenue and earnings and to continue to deliver shareholder value.
Conference Call and Webcast Information
Adtalem will hold a conference call to discuss its fiscal 2020 fourth quarter on Tuesday, August 18, 2020, at 4 p.m. CT (5 p.m. ET). The
conference call will be led by Lisa Wardell, chairman and chief executive officer, and Mike Randolfi, senior vice president and chief financial officer.
For those participating by telephone, dial 877-407-6184 (United States) or +1 201-389-0877 (outside the United States) and request the
“Adtalem Call” or use conference ID: 13707353. Adtalem will also broadcast the conference call live on the web at:
https://78449.themediaframe.com/dataconf/productusers/age/mediaframe/39843/indexl.html.
Please access the website at least 15 minutes prior to the start of the call to register, download and install any necessary audio
software.
Adtalem will archive a replay of the call until September
18, 2020. To access the replay, dial 877-660-6853 (United States) or +1 201-612-7415 (outside the United States), conference ID: 13707353, or visit the Adtalem website at: https://investors.adtalem.com/overview/default.aspx.
About Adtalem Global Education
The purpose of Adtalem Global
Education is to empower students to achieve their goals, find success, and make inspiring contributions to our global community. Adtalem Global Education Inc. (NYSE: ATGE; member S&P MidCap 400 Index) is a leading global education provider
and the parent organization of American University of the Caribbean School of Medicine, Association of Certified Anti-Money Laundering Specialists, Becker Professional Education, Chamberlain University, EduPristine, OnCourse Learning,
Ross University School of Medicine and Ross University School of Veterinary Medicine. For more information, please visit adtalem.com and
follow us on Twitter (@adtalemglobal) and LinkedIn.
Forward-Looking Statements
Certain statements contained in this release are forward-looking statements as defined in the
Private Securities Litigation Reform Act of 1995. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact,
which includes statements regarding the Company’s future growth and the future impacts of the COVID-19 pandemic. Forward-looking statements can also be identified by words such as “future,” “believe,” “expect,” “anticipate,” “estimate,” “plan,”
“intend,” “may,” “will,” “would,” “could,” “can,” “continue,” “preliminary,” “range,” and similar terms. These forward-looking statements are subject to risk and uncertainties that could cause actual results to differ materially from those
described in the statements. These risk and uncertainties include the risk factors described in Item 1A. “Risk Factors” of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) and our other filings
with the SEC. These forward-looking statements are based on information available to us as of the date any such statements are made, and we do not undertake any obligation to update any forward-looking statement, except as required by law.
|
4Q 2020
|
4Q 2019
|
% Change
|
|
|
Adtalem Global Education Student Enrollments(1)
|
|||
|
New students
|
4,757
|
4,493
|
+5.9%
|
|
Total students
|
38,593
|
36,087
|
+6.9%
|
|
Chamberlain University
|
|||
|
May Session
|
|||
|
New students
|
4,213
|
3,997
|
+5.4%
|
|
Total students
|
33,407
|
30,867
|
+8.2%
|
|
Medical and Veterinary(2)
|
|||
|
May Semester
|
|||
|
New students
|
544
|
496
|
+9.7%
|
|
Total students
|
5,186
|
5,220
|
-0.7%
|
|
1)
|
Includes the most recently reported enrollment sessions at Adtalem’s postsecondary institutions
|
|
2)
|
Includes enrollments in its medical and veterinary preparatory programs
|
Adtalem Global Education Inc.
Consolidated Balance Sheets
(unaudited)
(in thousands, except par value)
|
June 30,
|
||||||||
|
2020
|
2019
|
|||||||
|
Assets:
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
500,516
|
$
|
204,202
|
||||
|
Investments in marketable securities
|
8,968
|
8,680
|
||||||
|
Restricted cash
|
589
|
1,022
|
||||||
|
Accounts receivable, net
|
87,042
|
83,560
|
||||||
|
Prepaid expenses and other current assets
|
95,651
|
29,313
|
||||||
|
Current assets held for sale
|
—
|
177,923
|
||||||
|
Total current assets
|
692,766
|
504,700
|
||||||
|
Noncurrent assets:
|
||||||||
|
Property and equipment, net
|
286,102
|
283,433
|
||||||
|
Operating lease assets
|
174,935
|
—
|
||||||
|
Deferred income taxes
|
22,277
|
12,729
|
||||||
|
Intangible assets, net
|
287,514
|
297,989
|
||||||
|
Goodwill
|
686,214
|
687,256
|
||||||
|
Other assets, net
|
78,879
|
52,113
|
||||||
|
Other assets held for sale
|
—
|
404,476
|
||||||
|
Total noncurrent assets
|
1,535,921
|
1,737,996
|
||||||
|
Total assets
|
$
|
2,228,687
|
$
|
2,242,696
|
||||
|
Liabilities and shareholders' equity:
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$
|
46,484
|
$
|
53,385
|
||||
|
Accrued payroll and benefits
|
48,835
|
46,664
|
||||||
|
Accrued liabilities
|
104,431
|
76,529
|
||||||
|
Deferred revenue
|
91,589
|
95,944
|
||||||
|
Current operating lease liabilities
|
51,644
|
—
|
||||||
|
Current portion of long-term debt
|
3,000
|
3,000
|
||||||
|
Current liabilities held for sale
|
—
|
36,109
|
||||||
|
Total current liabilities
|
345,983
|
311,631
|
||||||
|
Noncurrent liabilities:
|
||||||||
|
Long-term debt
|
286,115
|
398,094
|
||||||
|
Long-term operating lease liabilities
|
176,032
|
—
|
||||||
|
Deferred income taxes
|
24,975
|
25,322
|
||||||
|
Other liabilities
|
82,309
|
83,508
|
||||||
|
Noncurrent liabilities held for sale
|
—
|
23,068
|
||||||
|
Total noncurrent liabilities
|
569,431
|
529,992
|
||||||
|
Total liabilities
|
915,414
|
841,623
|
||||||
|
Commitments and contingencies
|
||||||||
|
Redeemable noncontrolling interest
|
2,852
|
9,543
|
||||||
|
Shareholders' equity:
|
||||||||
|
Common stock, $0.01 par value per share, 200,000 shares authorized; 51,871 and 55,303 shares outstanding
as of June 30, 2020 and June 30, 2019, respectively
|
807
|
801
|
||||||
|
Additional paid-in capital
|
504,434
|
486,061
|
||||||
|
Retained earnings
|
1,927,568
|
2,012,902
|
||||||
|
Accumulated other comprehensive loss
|
(9,055
|
)
|
(137,290
|
)
|
||||
|
Treasury stock, at cost, 28,794 and 24,830 shares as of June 30, 2020 and June 30, 2019, respectively
|
(1,113,333
|
)
|
(970,944
|
)
|
||||
|
Total shareholders' equity
|
1,310,421
|
1,391,530
|
||||||
|
Total liabilities and shareholders' equity
|
$
|
2,228,687
|
$
|
2,242,696
|
||||
Adtalem Global Education Inc.
Consolidated Statements of Income (Loss)
(unaudited)
(in thousands, except per share data)
|
Three Months Ended
|
Year Ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Revenue
|
$
|
259,729
|
$
|
264,240
|
$
|
1,052,001
|
$
|
1,013,843
|
||||||||
|
Operating cost and expense:
|
||||||||||||||||
|
Cost of educational services
|
116,050
|
121,979
|
490,054
|
471,782
|
||||||||||||
|
Student services and administrative expense
|
103,669
|
90,181
|
395,838
|
359,342
|
||||||||||||
|
Restructuring expense
|
18,289
|
7,873
|
28,628
|
53,067
|
||||||||||||
|
Gain on sale of assets
|
—
|
—
|
(4,779
|
)
|
—
|
|||||||||||
|
Settlement gains
|
—
|
(10,607
|
)
|
—
|
(26,178
|
)
|
||||||||||
|
Total operating cost and expense
|
238,008
|
209,426
|
909,741
|
858,013
|
||||||||||||
|
Operating income
|
21,721
|
54,814
|
142,260
|
155,830
|
||||||||||||
|
Other income (expense):
|
||||||||||||||||
|
Interest and dividend income
|
1,013
|
764
|
3,688
|
3,968
|
||||||||||||
|
Interest expense
|
(3,925
|
)
|
(5,188
|
)
|
(19,510
|
)
|
(19,898
|
)
|
||||||||
|
Investment gain (loss)
|
1,124
|
254
|
18
|
(153
|
)
|
|||||||||||
|
Gain on derivative
|
26,891
|
—
|
110,723
|
—
|
||||||||||||
|
Net other income (expense)
|
25,103
|
(4,170
|
)
|
94,919
|
(16,083
|
)
|
||||||||||
|
Income from continuing operations before income taxes
|
46,824
|
50,644
|
237,179
|
139,747
|
||||||||||||
|
Benefit from (provision for) income taxes
|
24,571
|
(15,508
|
)
|
6,358
|
(32,878
|
)
|
||||||||||
|
Income from continuing operations
|
71,395
|
35,136
|
243,537
|
106,869
|
||||||||||||
|
Discontinued operations:
|
||||||||||||||||
|
(Loss) income from discontinued operations before income taxes
|
(57,042
|
)
|
14,532
|
(62,578
|
)
|
15,803
|
||||||||||
|
Loss on disposal of discontinued operations before income taxes (includes ($293,360) accumulated other
comprehensive income reclassifications for realized loss on foreign currency translation adjustments for the periods ended June 30, 2020)
|
(287,560
|
)
|
(625
|
)
|
(287,560
|
)
|
(33,604
|
)
|
||||||||
|
Benefit from income taxes
|
17,045
|
751
|
20,823
|
6,513
|
||||||||||||
|
(Loss) income from discontinued operations
|
(327,557
|
)
|
14,658
|
(329,315
|
)
|
(11,288
|
)
|
|||||||||
|
Net (loss) income
|
(256,162
|
)
|
49,794
|
(85,778
|
)
|
95,581
|
||||||||||
|
Net loss attributable to redeemable noncontrolling interest from continuing operations
|
110
|
113
|
444
|
378
|
||||||||||||
|
Net income attributable to redeemable noncontrolling interest from discontinued operations
|
—
|
(409
|
)
|
—
|
(791
|
)
|
||||||||||
|
Net (loss) income attributable to Adtalem Global Education
|
$
|
(256,052
|
)
|
$
|
49,498
|
$
|
(85,334
|
)
|
$
|
95,168
|
||||||
|
Amounts attributable to Adtalem Global Education:
|
||||||||||||||||
|
Net income from continuing operations
|
$
|
71,505
|
$
|
35,249
|
$
|
243,981
|
$
|
107,247
|
||||||||
|
Net (loss) income from discontinued operations
|
(327,557
|
)
|
14,249
|
(329,315
|
)
|
(12,079
|
)
|
|||||||||
|
Net (loss) income attributable to Adtalem Global Education
|
$
|
(256,052
|
)
|
$
|
49,498
|
$
|
(85,334
|
)
|
$
|
95,168
|
||||||
|
Earnings (loss) per share attributable to Adtalem Global Education:
|
||||||||||||||||
|
Basic:
|
||||||||||||||||
|
Continuing operations
|
$
|
1.37
|
$
|
0.62
|
$
|
4.55
|
$
|
1.83
|
||||||||
|
Discontinued operations
|
$
|
(6.27
|
)
|
$
|
0.25
|
$
|
(6.14
|
)
|
$
|
(0.21
|
)
|
|||||
|
Net
|
$
|
(4.90
|
)
|
$
|
0.88
|
$
|
(1.59
|
)
|
$
|
1.63
|
||||||
|
Diluted:
|
||||||||||||||||
|
Continuing operations
|
$
|
1.36
|
$
|
0.62
|
$
|
4.51
|
$
|
1.81
|
||||||||
|
Discontinued operations
|
$
|
(6.22
|
)
|
$
|
0.25
|
$
|
(6.09
|
)
|
$
|
(0.20
|
)
|
|||||
|
Net
|
$
|
(4.86
|
)
|
$
|
0.86
|
$
|
(1.58
|
)
|
$
|
1.60
|
||||||
|
Weighted-average shares outstanding:
|
||||||||||||||||
|
Basic shares
|
52,274
|
56,555
|
53,659
|
58,540
|
||||||||||||
|
Diluted shares
|
52,650
|
57,284
|
54,094
|
59,330
|
||||||||||||
Adtalem Global Education Inc.
Consolidated Statements of Cash Flows
(unaudited)
(unaudited)
(in thousands)
|
Year Ended June 30,
|
||||||||
|
2020
|
2019
|
|||||||
|
Operating activities:
|
||||||||
|
Net (loss) income
|
$
|
(85,778
|
)
|
$
|
95,581
|
|||
|
Loss from discontinued operations
|
329,315
|
11,288
|
||||||
|
Income from continuing operations
|
243,537
|
106,869
|
||||||
|
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
|
||||||||
|
Stock-based compensation expense
|
14,584
|
13,217
|
||||||
|
Amortization and adjustments to operating lease assets
|
54,716
|
—
|
||||||
|
Depreciation
|
34,428
|
33,759
|
||||||
|
Amortization
|
11,828
|
8,513
|
||||||
|
Provision for bad debts
|
16,152
|
9,817
|
||||||
|
Deferred income taxes
|
(4,548
|
)
|
20,752
|
|||||
|
Loss on disposals, accelerated depreciation, and adjustments to property and equipment
|
4,564
|
42,459
|
||||||
|
Realized and unrealized (gain) loss on investments
|
(18
|
)
|
153
|
|||||
|
Realized gain on sale of assets
|
(4,779
|
)
|
—
|
|||||
|
Insurance settlement gain
|
—
|
(15,571
|
)
|
|||||
|
Gain on derivative
|
(110,723
|
)
|
—
|
|||||
|
Changes in assets and liabilities:
|
||||||||
|
Accounts receivable
|
(12,840
|
)
|
(21,123
|
)
|
||||
|
Prepaid expenses and other current assets
|
(17,612
|
)
|
1,276
|
|||||
|
Accounts payable
|
(6,340
|
)
|
8,104
|
|||||
|
Accrued payroll and benefits
|
2,173
|
(3,350
|
)
|
|||||
|
Accrued liabilities
|
(2,477
|
)
|
7,719
|
|||||
|
Deferred revenue
|
(4,355
|
)
|
(6,058
|
)
|
||||
|
Operating lease liabilities
|
(53,726
|
)
|
—
|
|||||
|
Other assets and liabilities
|
(14,999
|
)
|
(21,082
|
)
|
||||
|
Net cash provided by operating activities-continuing operations
|
149,565
|
185,454
|
||||||
|
Net cash (used in) provided by operating activities-discontinued operations
|
(41,873
|
)
|
19,404
|
|||||
|
Net cash provided by operating activities
|
107,692
|
204,858
|
||||||
|
Investing activities:
|
||||||||
|
Capital expenditures
|
(44,137
|
)
|
(57,574
|
)
|
||||
|
Insurance proceeds received for damage to buildings and equipment
|
—
|
35,706
|
||||||
|
Proceeds from sales of marketable securities
|
2,829
|
1,841
|
||||||
|
Purchases of marketable securities
|
(3,015
|
)
|
(6,321
|
)
|
||||
|
Proceeds from sale of assets
|
6,421
|
—
|
||||||
|
Cash received on settlement of derivative
|
110,723
|
—
|
||||||
|
Cash received on purchase price adjustment
|
92
|
—
|
||||||
|
Payment for purchase of businesses, net of cash acquired
|
—
|
(118,409
|
)
|
|||||
|
Loan to DeVry University
|
—
|
(10,000
|
)
|
|||||
|
Net cash provided by (used in) investing activities-continuing operations
|
72,913
|
(154,757
|
)
|
|||||
|
Net cash used in investing activities-discontinued operations
|
(3,908
|
)
|
(9,010
|
)
|
||||
|
Proceeds from sale of business, net of cash transferred
|
313,518
|
—
|
||||||
|
Cash and restricted cash transferred in divestitures of discontinued operations
|
—
|
(50,069
|
)
|
|||||
|
Net cash provided by (used in) investing activities
|
382,523
|
(213,836
|
)
|
|||||
|
Financing activities:
|
||||||||
|
Proceeds from exercise of stock options
|
3,761
|
16,994
|
||||||
|
Employee taxes paid on withholding shares
|
(5,485
|
)
|
(6,801
|
)
|
||||
|
Proceeds from stock issued under Colleague Stock Purchase Plan
|
17
|
421
|
||||||
|
Repurchases of common stock for treasury
|
(136,889
|
)
|
(252,852
|
)
|
||||
|
Borrowings under credit facility
|
225,000
|
135,000
|
||||||
|
Repayments under credit facility
|
(338,000
|
)
|
(28,000
|
)
|
||||
|
Proceeds from down payment on seller loan
|
5,200
|
—
|
||||||
|
Payment for purchase of redeemable noncontrolling interest of subsidiary
|
(6,247
|
)
|
—
|
|||||
|
Net cash used in financing activities-continuing operations
|
(252,643
|
)
|
(135,238
|
)
|
||||
|
Net cash used in financing activities-discontinued operations
|
(3,466
|
)
|
(2,295
|
)
|
||||
|
Net cash used in financing operations
|
(256,109
|
)
|
(137,533
|
)
|
||||
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
(33,468
|
)
|
2,573
|
|||||
|
Net increase (decrease) in cash, cash equivalents and restricted cash
|
200,638
|
(143,938
|
)
|
|||||
|
Cash, cash equivalents and restricted cash at beginning of period
|
300,467
|
444,405
|
||||||
|
Cash, cash equivalents and restricted cash at end of period
|
501,105
|
300,467
|
||||||
|
Less: cash, cash equivalents and restricted cash of discontinued operations at end of period
|
—
|
95,243
|
||||||
|
Cash, cash equivalents and restricted cash at end of period
|
$
|
501,105
|
$
|
205,224
|
||||
Adtalem Global Education Inc.
Segment Information
(unaudited)
(in thousands)
|
Three Months Ended
|
Year Ended
|
|||||||||||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||||||||||
|
2020
|
2019
|
Increase
(Decrease) |
2020
|
2019
|
Increase
(Decrease) |
|||||||||||||||||||
|
Revenue:
|
||||||||||||||||||||||||
|
Medical and Healthcare
|
$
|
211,417
|
$
|
211,559
|
(0.1
|
)%
|
$
|
866,428
|
$
|
849,861
|
1.9
|
%
|
||||||||||||
|
Financial Services
|
48,312
|
53,488
|
(9.7
|
)%
|
185,573
|
167,211
|
11.0
|
%
|
||||||||||||||||
|
Home Office and Other
|
—
|
(807
|
)
|
NM
|
—
|
(3,229
|
)
|
NM
|
||||||||||||||||
|
Total consolidated revenue
|
$
|
259,729
|
$
|
264,240
|
(1.7
|
)%
|
$
|
1,052,001
|
$
|
1,013,843
|
3.8
|
%
|
||||||||||||
|
Operating income (loss):
|
||||||||||||||||||||||||
|
Medical and Healthcare
|
$
|
39,605
|
$
|
39,726
|
(0.3
|
)%
|
$
|
166,037
|
$
|
155,122
|
7.0
|
%
|
||||||||||||
|
Financial Services
|
6,762
|
14,694
|
(54.0
|
)%
|
17,622
|
34,163
|
(48.4
|
)%
|
||||||||||||||||
|
Home Office and Other
|
(24,646
|
)
|
394
|
NM
|
(41,399
|
)
|
(33,455
|
)
|
(23.7
|
)%
|
||||||||||||||
|
Total consolidated operating income
|
$
|
21,721
|
$
|
54,814
|
(60.4
|
)%
|
$
|
142,260
|
$
|
155,830
|
(8.7
|
)%
|
||||||||||||
Non-GAAP Financial Measures and Reconciliations
We believe that certain non-GAAP financial measures provides investors with useful supplemental information regarding the underlying business trends and
performance of Adtalem’s ongoing operations and is useful for period-over-period comparisons. We use these supplemental non-GAAP financial measures internally in our assessment of performance and budgeting process. However, these non-GAAP financial
measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. The following are non-GAAP financial measures used in the subsequent GAAP to non-GAAP reconciliation tables:
Net income from continuing operations attributable to
Adtalem excluding special items (most comparable GAAP measure: net (loss) income attributable to Adtalem) – Measure of Adtalem’s net (loss) income attributable to Adtalem adjusted for restructuring expense, gain on sale of assets,
settlement gains, gain on derivative, tax charges related to the Tax Cuts and Jobs Act of 2017 and the divestiture of DeVry University, a net tax benefit for a former subsidiary investment loss, and loss (income) from discontinued operations.
Earnings per share from continuing operations excluding
special items (most comparable GAAP measure: (loss) earnings per share) – Measure of Adtalem’s diluted (loss) earnings per share adjusted for restructuring expense, gain on sale of assets, settlement gains, gain on derivative, tax charges
related to the Tax Cuts and Jobs Act of 2017 and the divestiture of DeVry University, a net tax benefit for a former subsidiary investment loss, and loss (income) from discontinued operations.
Operating income excluding special items (most comparable
GAAP measure: operating income) – Measure of Adtalem’s operating income adjusted for restructuring expense, gain on sale of assets, and settlement gains. This measure is applied on a consolidated and segment basis, depending on the context
of the discussion.
A description of special items in our non-GAAP financial measures described above are as follows:
|
●
|
Restructuring charges primarily related to the sale of Becker’s courses for healthcare students, Adtalem’s home office and ACAMS real estate
consolidations, workforce reductions across the organization, and the closing of the Ross University School of Medicine (“RUSM”) campus in Dominica. The workforce reduction of 32 positions in the fourth quarter of fiscal year 2020 was
driven by the desire to become more cost effective in response to COVID-19.
|
|
●
|
Gain on the sale of Adtalem’s Columbus, Ohio, campus facility.
|
|
●
|
Settlement gains related to the final insurance settlement related to Hurricanes Irma and Maria at the American University of the Caribbean
School of Medicine (“AUC”) and RUSM and a lawsuit settlement against the Adtalem Board of Directors.
|
|
●
|
Gain on the deal-contingent foreign currency hedge arrangement entered into in connection with the sale of Adtalem Brazil completed on April
24, 2020 to economically hedge the Brazilian Real denominated purchase price through mitigation of the currency exchange rate risk.
|
|
●
|
Tax charges related to the Tax Cuts and Jobs Act of 2017 and the divestiture of DeVry University.
|
|
●
|
A net tax benefit for a former subsidiary investment loss.
|
|
●
|
Loss (income) from discontinued operations include the operations of Adtalem Brazil, Carrington, and DeVry University.
|
Adtalem Global Education Inc.
Non-GAAP Operating Income from Continuing Operations by Segment
(unaudited)
(in thousands)
|
Three Months Ended
|
Year Ended
|
|||||||||||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||||||||||
|
2020
|
2019
|
Increase
(Decrease) |
2020
|
2019
|
Increase
(Decrease) |
|||||||||||||||||||
|
Medical and Healthcare:
|
||||||||||||||||||||||||
|
Operating income (GAAP)
|
$
|
39,605
|
$
|
39,726
|
(0.3
|
)%
|
$
|
166,037
|
$
|
155,122
|
7.0
|
%
|
||||||||||||
|
Restructuring expense
|
353
|
339
|
4.1
|
%
|
1,707
|
41,666
|
(95.9
|
)%
|
||||||||||||||||
|
Settlement gains
|
—
|
—
|
NM
|
—
|
(15,571
|
)
|
NM
|
|||||||||||||||||
|
Operating income excluding special items (non-GAAP)
|
$
|
39,958
|
$
|
40,065
|
(0.3
|
)%
|
$
|
167,744
|
$
|
181,217
|
(7.4
|
)%
|
||||||||||||
|
Financial Services:
|
||||||||||||||||||||||||
|
Operating income (GAAP)
|
$
|
6,762
|
$
|
14,694
|
(54.0
|
)%
|
$
|
17,622
|
$
|
34,163
|
(48.4
|
)%
|
||||||||||||
|
Restructuring expense
|
1,726
|
1,304
|
32.4
|
%
|
4,842
|
1,304
|
271.3
|
%
|
||||||||||||||||
|
Operating income excluding special items (non-GAAP)
|
$
|
8,488
|
$
|
15,998
|
(46.9
|
)%
|
$
|
22,464
|
$
|
35,467
|
(36.7
|
)%
|
||||||||||||
|
Home Office and Other:
|
||||||||||||||||||||||||
|
Operating (loss) income (GAAP)
|
$
|
(24,646
|
)
|
$
|
394
|
NM
|
$
|
(41,399
|
)
|
$
|
(33,455
|
)
|
(23.7
|
)%
|
||||||||||
|
Restructuring expense
|
16,210
|
6,230
|
160.2
|
%
|
22,079
|
10,097
|
118.7
|
%
|
||||||||||||||||
|
Gain on sale of assets
|
—
|
—
|
NM
|
(4,779
|
)
|
—
|
NM
|
|||||||||||||||||
|
Settlement gains
|
—
|
(10,607
|
)
|
NM
|
—
|
(10,607
|
)
|
NM
|
||||||||||||||||
|
Operating loss excluding special items (non-GAAP)
|
$
|
(8,436
|
)
|
$
|
(3,983
|
)
|
(111.8
|
)%
|
$
|
(24,099
|
)
|
$
|
(33,965
|
)
|
29.0
|
%
|
||||||||
|
Adtalem Global Education:
|
||||||||||||||||||||||||
|
Operating income (GAAP)
|
$
|
21,721
|
$
|
54,814
|
(60.4
|
)%
|
$
|
142,260
|
$
|
155,830
|
(8.7
|
)%
|
||||||||||||
|
Restructuring expense
|
18,289
|
7,873
|
132.3
|
%
|
28,628
|
53,067
|
(46.1
|
)%
|
||||||||||||||||
|
Gain on sale of assets
|
—
|
—
|
NM
|
(4,779
|
)
|
—
|
NM
|
|||||||||||||||||
|
Settlement gains
|
—
|
(10,607
|
)
|
NM
|
—
|
(26,178
|
)
|
NM
|
||||||||||||||||
|
Operating income excluding special items (non-GAAP)
|
$
|
40,010
|
$
|
52,080
|
(23.2
|
)%
|
$
|
166,109
|
$
|
182,719
|
(9.1
|
)%
|
||||||||||||
Adtalem Global Education Inc.
Non-GAAP Earnings Disclosure
(unaudited)
(in thousands, except per share data)
|
Three Months Ended
|
Year Ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Net (loss) income attributable to Adtalem (GAAP)
|
$
|
(256,052
|
)
|
$
|
49,498
|
$
|
(85,334
|
)
|
$
|
95,168
|
||||||
|
Restructuring expense
|
18,289
|
7,873
|
28,628
|
53,067
|
||||||||||||
|
Gain on sale of assets
|
—
|
—
|
(4,779
|
)
|
—
|
|||||||||||
|
Settlement gains
|
—
|
(10,607
|
)
|
—
|
(26,178
|
)
|
||||||||||
|
Gain on derivative
|
(26,891
|
)
|
—
|
(110,723
|
)
|
—
|
||||||||||
|
Tax Cuts and Jobs Act of 2017 and tax charges related to the divestiture of DeVry University
|
(2,230
|
)
|
2,058
|
(2,230
|
)
|
3,584
|
||||||||||
|
Net tax benefit for a former subsidiary investment loss
|
(25,688
|
)
|
—
|
(25,688
|
)
|
—
|
||||||||||
|
Income tax impact on non-GAAP adjustments (1)
|
(4,483
|
)
|
3,235
|
(5,648
|
)
|
(1,560
|
)
|
|||||||||
|
Loss (income) from discontinued operations
|
327,557
|
(14,249
|
)
|
329,315
|
12,079
|
|||||||||||
|
Net income from continuing operations attributable to Adtalem
excluding special items (non-GAAP)
|
$
|
30,502
|
$
|
37,808
|
$
|
123,541
|
$
|
136,160
|
||||||||
(1) Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements.
|
Three Months Ended
|
Year Ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
(Loss) earnings per share, diluted (GAAP)
|
$
|
(4.86
|
)
|
$
|
0.86
|
$
|
(1.58
|
)
|
$
|
1.60
|
||||||
|
Effect on diluted earnings per share:
|
||||||||||||||||
|
Restructuring expense
|
0.35
|
0.14
|
0.53
|
0.89
|
||||||||||||
|
Gain on sale of assets
|
—
|
—
|
(0.09
|
)
|
—
|
|||||||||||
|
Settlement gains
|
—
|
(0.19
|
)
|
—
|
(0.44
|
)
|
||||||||||
|
Gain on derivative
|
(0.51
|
)
|
—
|
(2.05
|
)
|
—
|
||||||||||
|
Tax Cuts and Jobs Act of 2017 and tax charges related to the divestiture of DeVry University
|
(0.04
|
)
|
0.04
|
(0.04
|
)
|
0.06
|
||||||||||
|
Net tax benefit for a former subsidiary investment loss
|
(0.49
|
)
|
—
|
(0.47
|
)
|
—
|
||||||||||
|
Income tax impact on non-GAAP adjustments (1)
|
(0.09
|
)
|
0.06
|
(0.10
|
)
|
(0.03
|
)
|
|||||||||
|
Loss (income) from discontinued operations
|
6.22
|
(0.25
|
)
|
6.09
|
0.20
|
|||||||||||
|
Earnings per share from continuing operations excluding special
items, diluted (non-GAAP)
|
$
|
0.58
|
$
|
0.66
|
$
|
2.28
|
$
|
2.29
|
||||||||
|
Diluted shares used in EPS calculation
|
52,650
|
57,284
|
54,094
|
59,330
|
||||||||||||
(1) Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements.